Evaluating the Role of IL-6-174 G/C (rs1800795) Gene Polymorphism in Modulating Serum Levels of Some Inflammatory Biomarker and Therapeutic Outcomes with Rituximab in Iraqi Rheumatoid Arthritis Patients
Rituximab is a chimeric monoclonal antibody used in the treatment of rheumatoid arthritis (RA). However, patients receiving it show various degrees of responsiveness without knowing the exact causes behind this diversity. Interleukin-6, among other inflammatory biomarkers, is involved in RA pathogenicity. This study in...